Emerson Acquires Bioproduction Group to Expand Digital Ecosystem and Accelerate Development of Therapies for Diseases Including Cancer and Diabetes

VCBeat (WeChat ID: vcbeat) has learned that Emerson Electric Co. (hereinafter referred to as “Emerson”) recently announced the acquisition of Bioproduction Group (hereinafter referred to as “Bio-G”). Specific details of the transaction were not disclosed.

BIO-G boasts leading modeling and planning software solutions, while Emerson offers advanced technical expertise and a broad portfolio of life sciences products. This acquisition enables the two companies to combine their respective strengths and specialties, jointly helping life sciences companies accelerate the development of new therapies for cancer, diabetes, and other diseases.

Upon completion of the acquisition, BIO-G’s modeling and planning software will become part of Emerson’s Plantweb digital ecosystem, its industrial Internet of Things (IIoT) portfolio. By integrating BIO-G’s analysis and modeling tools with Emerson’s automation and operational systems, such as the DeltaV distributed control system and the Syncade manufacturing execution system, the solution provides a comprehensive view of operations, maintenance, and enterprise systems, helping Emerson extend digital intelligence across the entire biomanufacturing industry.

Furthermore, leveraging BIO-G’s real-time modeling software, Emerson can provide predictive analytics for plant operations, thereby enhancing the company’s efficiency in the manufacturing process. Notably, this modeling software offers enterprises capabilities in capacity engineering, debottlenecking, and transfer analysis, helping to identify obstacles in the manufacturing process and maximize production.

Emerson, founded in 1890 and headquartered in St. Louis, Missouri, USA, is an industrial technology company. The company holds a dominant position in the convergence of technology and engineering, dedicated to providing innovative solutions in the fields of industrial automation, process control, heating, ventilation and air conditioning (HVAC), electronics and telecommunications, as well as appliances and tools. These solutions help customers enhance production efficiency, protect the environment, and ensure personnel safety.

BIO-G, a biotechnology company founded in 2007 and headquartered in California, USA, is a leader in developing simulation, modeling, and planning software for the life sciences industry. Its software solutions enable enterprises to accurately predict facility resource availability and optimize manufacturing performance, thereby extending equipment uptime and reducing product loss, which helps life sciences companies accelerate their research and development efforts.

Emerson President Tom Snead stated, “By integrating BIO-G’s planning and modeling software with Emerson’s digital ecosystem, we are able to continue developing novel therapeutic solutions for patients with diabetes, Alzheimer’s disease, immuno-oncology (IO) indications, and other conditions.”

(Compiled by Jiao Yanli)